Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 2, 2014, Pages 330-337

  Ji, Zhe ^a   Bi, Nan ^a   Wang, Jingbo ^a   Hui, Zhouguang ^a   Xiao, Zefen ^a   Feng, Qinfu ^a   Zhou, Zongmei ^a   Chen, Dongfu ^a   Lv, Jima ^a   Liang, Jun ^a   Fan, Chengcheng ^a   Liu, Lipin ^a   Wang, Luhua ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CELLS; CYTOLOGY; DISEASES; FACTOR ANALYSIS; MULTIVARIANT ANALYSIS; PATHOLOGY; RADIOTHERAPY; REGRESSION ANALYSIS; TUMORS;

COX REGRESSION ANALYSIS; LACTATE DEHYDROGENASE; LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCERS; LYMPH NODE METASTASIS; MULTI VARIATE ANALYSIS; PREVENTION STRATEGIES; PROPHYLACTIC CRANIAL IRRADIATIONS; SQUAMOUS CELL CARCINOMA;

RISK ASSESSMENT;

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE;

ADVANCED CANCER; AGE; ARTICLE; ATELECTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; DEFINITIVE CHEST RADIATION; DISTANT METASTASIS; FEMININITY; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NON SQUAMOUS CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; RETROSPECTIVE STUDY; SKIN CARCINOMA; SKULL IRRADIATION; SUPERIOR CAVA VEIN SYNDROME; SURVIVAL TIME; SYSTEMIC THERAPY;

AGE FACTORS; BRAIN NEOPLASMS; CA-125 ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; CRANIAL IRRADIATION; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHOPYRUVATE HYDRATASE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84899923900     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.02.025     Document Type: Article

References (33)

1. The diagnosis and treatment of lung cancer (update) 2011 National Collaborating Centre for Cancer Cardiff, UK
2. M. Stuschke, W. Eberhardt, and C. Pottgen et al. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic effects J Clin Oncol 17 1999 2700 2709
3. F. Andre, D. Grunenwald, and J.L. Pujol et al. Patterns of relapse of n2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered? Cancer 91 2001 2394 2400
4. H. Carolan, A.Y. Sun, and A. Bezjak et al. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? Lung Cancer 49 2005 109 115
5. L. Kepka, E. Cieslak, and K. Bujko et al. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: The RTOG RPA intra-classes analysis Acta Oncol 44 2005 389 398
6. C.J. Langer, and M.P. Mehta Current management of brain metastases, with a focus on systemic options J Clin Oncol 23 2005 6207 6219
7. J.D. Cox, K. Stanley, and Z. Petrovich et al. Cranial irradiation in cancer of the lung of all cell types JAMA 245 1981 469 472
8. T. Umsawasdi, M. Valdivieso, and T.T. Chen et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer J Neurooncol 2 1984 253 259
9. A.H. Russell, T.E. Pajak, and H.M. Selim et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 21 1991 637 643
10. E.M. Gore, K. Bae, and S.J. Wong et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: Primary analysis of Radiation Therapy Oncology Group study RTOG 0214 J Clin Oncol 29 2011 272 278
11. J.D. Cox, C.B. Scott, and R.W. Byhardt et al. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of Radiation Therapy Oncology Group (RTOG) trials Int J Radiat Oncol Biol Phys 43 1999 505 509
12. R. Komaki, C.B. Scott, and R. Byhardt et al. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four Radiation Therapy Oncology Group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 42 1998 263 267
13. A.M. Chen, T.M. Jahan, and D.M. Jablons et al. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: Clinical implications for the subsequent management of the brain Cancer 109 2007 1668 1675
14. P.E. Postmus, and E.F. Smit Chemotherapy for brain metastases of lung cancer: a review Ann Oncol 10 1999 753 759
15. L.E. Abrey, J.D. Olson, and J.J. Raizer et al. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases J Neurooncol 53 2001 259 265
16. G.L. Ceresoli, M. Reni, and G. Chiesa et al. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis Cancer 95 2002 605 612
17. A. Bajard, V. Westeel, and A. Dubiez et al. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma Lung Cancer 45 2004 317 323
18. C. Dimitropoulos, G. Hillas, and S. Nikolakopoulou et al. Prophylactic cranial irradiation in non-small cell lung cancer patients: Who might be the candidates? Cancer Manag Res 3 2011 287 294
19. I.J. Fidler, S. Yano, and R.D. Zhang et al. The seed and soil hypothesis: Vascularisation and brain metastases Lancet Oncol 3 2002 53 57
20. A.G. Saad, B.Y. Yeap, and F.B. Thunnissen et al. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma Cancer 113 2008 2129 2138
21. L.E. Gaspar, K. Chansky, and K.S. Albain et al. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: A retrospective review by the Southwest Oncology Group J Clin Oncol 23 2005 2955 2961
22. A. Mujoomdar, J.H. Austin, and R. Malhotra et al. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: Primary tumor size, cell type, and lymph node metastases Radiology 242 2007 882 888
23. O. Arrieta, D. Saavedra-Perez, and R. Kuri et al. Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: A prospective analysis BMC Cancer 9 2009 119
24. B. Keith, M. Vincent, and L. Stitt et al. Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small-cell lung cancer Am J Clin Oncol 25 2002 583 587
25. V. Barak, S. Holdenrieder, and B. Nisman et al. Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer Cancer Biomark 6 2010 191 196
26. S. Cedres, I. Nunez, and M. Longo et al. Serum tumor markers cea, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC) Clin Lung Cancer 12 2011 172 179
27. M. van de Pol, A. Twijnstra, and G.P. ten Velde et al. Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma J Neurooncol 19 1994 149 154
28. W. Jacot, X. Quantin, and J.M. Boher et al. Brain metastases at the time of presentation of non-small cell lung cancer: A multi-centric aerio analysis of prognostic factors Br J Cancer 84 2001 903 909
29. T.J. Robnett, M. Machtay, and J.P. Stevenson et al. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma J Clin Oncol 19 2001 1344 1349
30. E. Topkan, C. Parlak, and A. Kotek et al. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with Stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens Int J Radiat Oncol Biol Phys 83 2012 1264 1271
31. K. Furuse, M. Fukuoka, and M. Kawahara et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
32. H. Horinouchi, I. Sekine, and M. Sumi et al. Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: Carcinoembryonic antigen as a potential predictive factor Cancer Sci 103 2012 756 759
33. F. Germain, E.S. Wai, and E. Berthelet et al. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy Am J Clin Oncol 31 2008 561 566